1-247451088-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004492.2(OR2B11):c.895A>C(p.Lys299Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001004492.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2B11 | NM_001004492.2 | c.895A>C | p.Lys299Gln | missense_variant | 2/2 | ENST00000641149.2 | NP_001004492.1 | |
OR2B11 | NR_169840.1 | n.1549A>C | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2B11 | ENST00000641149.2 | c.895A>C | p.Lys299Gln | missense_variant | 2/2 | NM_001004492.2 | ENSP00000492892.1 | |||
OR2B11 | ENST00000641527.1 | c.895A>C | p.Lys299Gln | missense_variant | 3/3 | ENSP00000493421.1 | ||||
OR2B11 | ENST00000641613.1 | n.1549A>C | non_coding_transcript_exon_variant | 5/5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.895A>C (p.K299Q) alteration is located in exon 1 (coding exon 1) of the OR2B11 gene. This alteration results from a A to C substitution at nucleotide position 895, causing the lysine (K) at amino acid position 299 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.